Literature DB >> 35040081

Macrophage Nuclear Receptor Corepressor 1 Deficiency Protects Against Ischemic Stroke in Mice.

Shuai Shao1, Yan-Lin Chen1, Lin-Juan Du2,3, Yuan Liu2,3, Hong Zhu2,3, Lu-Jun Zhou2,3, Ting Liu2,3, Wen-Zhen Lin2,3, Fei Yu2,3, Xiao-Xin Ma2,3, Xue-Rui Shi2,3, Xiao-Qian Meng2,3, Yan Liu2,3, Yong-Li Wang2,3, Lan Bai2,3, Xiao-Hua Zhang4, Feng Jia1, Sheng-Zhong Duan2,3.   

Abstract

Microglia/macrophage activation plays an essential role in Ischemic stroke (IS). Nuclear receptor corepressor 1 (NCoR1) has been identified as a vital regulator in macrophages. The present study aims to explore the functions of macrophage NCoR1 in IS. Macrophage NCoR1 knockout (MNKO) mice and littermate control mice were subjected to middle cerebral artery occlusion (MCAO). Our data showed that macrophage NCoR1 deficiency significantly reduced the infarct size and infarct volume as well as brain edema after MCAO. Additionally, MNKO induced less microglia/macrophage infiltration and activation, neuroinflammation, apoptosis of neuronal cells, and BBB disruption in brains after IS. Mechanistic studies revealed that NCoR1 interacted with LXRβ in microglia and MNKO impaired the activation of the Nuclear factor-κB signaling pathway in brains after IS. Our data demonstrated that macrophage NCoR1 deficiency inhibited microglia/macrophage activation and protected against IS. Targeting NCoR1 in microglia/macrophage may be a potential approach for IS treatment.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Ischemic stroke; Microglia/macrophage activation; Neuroinflammation; Nuclear receptor corepressors 1

Year:  2022        PMID: 35040081     DOI: 10.1007/s12265-021-10187-9

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  34 in total

Review 1.  Myeloid cells as therapeutic targets in neuroinflammation after stroke: Specific roles of neutrophils and neutrophil-platelet interactions.

Authors:  Alicia García-Culebras; Violeta Durán-Laforet; Carolina Peña-Martínez; Iván Ballesteros; Jesús M Pradillo; Jaime Díaz-Guzmán; Ignacio Lizasoain; María A Moro
Journal:  J Cereb Blood Flow Metab       Date:  2018-08-21       Impact factor: 6.200

Review 2.  Functions and mechanisms of microglia/macrophages in neuroinflammation and neurogenesis after stroke.

Authors:  Xiao-Yi Xiong; Liang Liu; Qing-Wu Yang
Journal:  Prog Neurobiol       Date:  2016-05-07       Impact factor: 11.685

Review 3.  Autophagy in ischemic stroke.

Authors:  Pei Wang; Bo-Zong Shao; Zhiqiang Deng; Shi Chen; Zhenyu Yue; Chao-Yu Miao
Journal:  Prog Neurobiol       Date:  2018-01-10       Impact factor: 11.685

Review 4.  Ischaemic stroke.

Authors:  Bruce C V Campbell; Deidre A De Silva; Malcolm R Macleod; Shelagh B Coutts; Lee H Schwamm; Stephen M Davis; Geoffrey A Donnan
Journal:  Nat Rev Dis Primers       Date:  2019-10-10       Impact factor: 52.329

Review 5.  Management of acute ischemic stroke.

Authors:  Michael S Phipps; Carolyn A Cronin
Journal:  BMJ       Date:  2020-02-13

Review 6.  The biphasic function of microglia in ischemic stroke.

Authors:  Yuanyuan Ma; Jixian Wang; Yongting Wang; Guo-Yuan Yang
Journal:  Prog Neurobiol       Date:  2016-02-02       Impact factor: 11.685

Review 7.  Immune interventions in stroke.

Authors:  Ying Fu; Qiang Liu; Josef Anrather; Fu-Dong Shi
Journal:  Nat Rev Neurol       Date:  2015-08-25       Impact factor: 42.937

Review 8.  Inflammation and glial responses in ischemic brain lesions.

Authors:  G Stoll; S Jander; M Schroeter
Journal:  Prog Neurobiol       Date:  1998-10       Impact factor: 11.685

Review 9.  Acute Ischemic Stroke Intervention.

Authors:  Priyank Khandelwal; Dileep R Yavagal; Ralph L Sacco
Journal:  J Am Coll Cardiol       Date:  2016-06-07       Impact factor: 24.094

Review 10.  Neuroinflammation: friend and foe for ischemic stroke.

Authors:  Richard L Jayaraj; Sheikh Azimullah; Rami Beiram; Fakhreya Y Jalal; Gary A Rosenberg
Journal:  J Neuroinflammation       Date:  2019-07-10       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.